©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2723-2730
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2723
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2723
Table 1 Baseline characteristics of patients and therapeutic approaches (n = 83) n (%)
| Type II (n = 62) | Type III (n = 21) | P value | |
| Age (yr) | 0.72 | ||
| Median (range) | 68.5 (33-87) | 69 (54-80) | |
| Sex | 0.78 | ||
| Male | 49 (79) | 16 (76) | |
| Female | 13 (21) | 5 (24) | |
| Tumor size (mm) | 50 (10-168) | 70 (12-120) | 0.016 |
| Esophageal invasion (mm) | 9 (0-85) | 5 (0-15) | 0.024 |
| Total number of examined lymph nodes | 36.5 (5-96) | 51 (22-80) | 0.016 |
| Approach | |||
| Right thoracic | 8 (13) | 0 (0) | |
| Left thoracic | 8 (13) | 1 (5) | |
| Transhiatal | 46 (74) | 20 (95) | |
| Resection method | |||
| Subtotal esophagectomy | 8 (13) | 0 (0) | |
| Total gastrectomy with distal esophagectomy | 37 (60) | 21 (100) | |
| Proximal gastrectomy with distal esophagectomy | 17 (27) | 0 (0) | |
| Adjuvant chemotherapy | 0.24 | ||
| Yes | 19 (31) | 9 (43) | |
| No | 43 (69) | 12 (57) |
- Citation: Hosoda K, Yamashita K, Moriya H, Mieno H, Watanabe M. Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up. World J Gastroenterol 2017; 23(15): 2723-2730
- URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2723.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2723